Skip to content

Drug interactions

Medroxyprogesterone + Ribociclib

Severity: Minor

Medroxyprogesterone and Ribociclib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ribociclib may increase medroxyprogesterone exposure, potentially increasing progestogenic adverse effects. The effect is probably modest.

What this interaction means in plain words

Medroxyprogesterone and Ribociclib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Medroxyprogesterone belongs to Endocrine; Ribociclib belongs to Oncology.

Evidence level: Low

Why it happens

Ribociclib inhibits CYP3A4, reducing medroxyprogesterone metabolism.

What to do

No routine change is needed. Monitor for progestogenic adverse effects such as fluid retention or mood change.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Medroxyprogesterone and Ribociclib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Medroxyprogesterone with Ribociclib?

MediHelp rates the interaction as minor. Medroxyprogesterone and Ribociclib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ribociclib may increase medroxyprogesterone exposure, potentially increasing progestogenic adverse effects. The effect is probably modest.

How serious is the interaction between Medroxyprogesterone and Ribociclib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed. Monitor for progestogenic adverse effects such as fluid retention or mood change.

What other medicines interact with Medroxyprogesterone?

MediHelp also lists interactions of Medroxyprogesterone with, for example, Bosentan, Brigatinib, Eslicarbazepine. The full list is on the Medroxyprogesterone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in